» Articles » PMID: 32922196

Study of Weight and Body Mass Index on Graft Loss After Transplant over 5 Years of Evolution

Overview
Journal Int J Med Sci
Specialty General Medicine
Date 2020 Sep 14
PMID 32922196
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Patients frequently experience a weight gain after organ transplantation. This increase in weight is the result of multiple factors, and is usually intensified by glucocorticoids and immunosuppressive drugs. It can also delay graft function and cause serious health problems. The objective of this study was to study the obesity as well as its causes and consequences in kidney transplant patients. The sample population consisted of 282 renal transplant patients, 170 men and 112 women, 18-74 years of age, who were monitored over a period of five years. For the purposes of our research, the patients were divided into two groups: (1) normal weight 18.5 ≤ BMI <25; (2) overweight 25 ≤ BMI ≤30. The association between BMI as an independent variable and graft survival was determined by means of a Cox regression analysis. Overweight patients were characterized by a higher comorbidity prevalence. In the Cox multivariate analysis, the initial BMI, evaluated as a continuous variable continued to be an independent predictor of delayed graft function and chronic nephropathy. This study evaluated the BMI as a continuous value instead of a categorical value. In conclusion, our results suggest that an increase in BMI without categorical variation can be an independent risk factor for graft loss. Consequently, obesity prevention for renal transplant patients should include dietary counseling and management, moderate physical activity, and steroid minimization.

Citing Articles

Beneficial effects of physical exercise on the osteo-renal Klotho-FGF-23 axis in Chronic Kidney Disease: A systematic review with meta-analysis.

Castillo R, Perez R, Gonzalez A Int J Med Sci. 2024; 21(2):332-340.

PMID: 38169578 PMC: 10758140. DOI: 10.7150/ijms.90195.


Therapeutic Applications and Effects of (Blue Lupin) and Its Components: A Systematic Review and Meta-Analysis.

Castillo R, Perez R, Gonzalez Diaz A, Gonzalez A Foods. 2023; 12(14).

PMID: 37509841 PMC: 10378960. DOI: 10.3390/foods12142749.

References
1.
Suarez O, Pardo M, Gonzalez S, Escobar-Serna D, Castaneda D, Rodriguez D . Diabetes mellitus and renal transplantation in adults: is there enough evidence for diagnosis, treatment, and prevention of new-onset diabetes after renal transplantation?. Transplant Proc. 2014; 46(9):3015-20. DOI: 10.1016/j.transproceed.2014.07.011. View

2.
Erturk T, Berber I, Cakir U . Effect of Obesity on Clinical Outcomes of Kidney Transplant Patients. Transplant Proc. 2019; 51(4):1093-1095. DOI: 10.1016/j.transproceed.2019.02.012. View

3.
Luyckx V, Tuttle K, Garcia-Garcia G, Gharbi M, Heerspink H, Johnson D . Reducing major risk factors for chronic kidney disease. Kidney Int Suppl (2011). 2019; 7(2):71-87. PMC: 6341126. DOI: 10.1016/j.kisu.2017.07.003. View

4.
Hall M, do Carmo J, da Silva A, Juncos L, Wang Z, Hall J . Obesity, hypertension, and chronic kidney disease. Int J Nephrol Renovasc Dis. 2014; 7:75-88. PMC: 3933708. DOI: 10.2147/IJNRD.S39739. View

5.
Teplan V, Schuck O, Racek J, Siroka R, Haluzik M, Kudla M . Asymmetric dimethylarginine and adiponectin after renal transplantation: role of obesity. J Ren Nutr. 2007; 18(1):154-7. DOI: 10.1053/j.jrn.2007.10.030. View